NK cell activity controls human herpesvirus 8 latent infection and is restored upon highly active antiretroviral therapy in AIDS patients with regressing Kaposi's sarcoma

European Journal of Immunology

Volumn 32, Issue 10, 2002, Pages 2711-2720

  Sirianni, Maria Caterina ^a   Vincenzi, Laura ^a   Topino, Simone ^a   Giovannetti, Antonello ^a   Mazzetta, Francesca ^a   Libi, Fabio ^a   Scaramuzzi, Donato ^a   Andreoni, Massimo ^b   Pinter, Elena ^a   Baccarini, Sara ^c   Rezza, Giovanni ^c   Monini, Paolo ^c   Ensoli, Barbara ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Highly active antiretroviral therapy; Kaposi's sarcoma; Kaposi's sarcoma associated herpesvirus; NK cell

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT; CD16 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; DAUNORUBICIN; INDINAVIR; NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR; RITONAVIR; VIRUS ANTIBODY; VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BLOOD DONOR; CELL FUNCTION; CELL MEDIATED CYTOTOXICITY; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; IMMUNE RESPONSE; KAPOSI SARCOMA; MALE; MONONUCLEAR CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; REMISSION; VIREMIA; VIRUS INFECTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIBODIES, VIRAL; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CYTOTOXICITY, IMMUNOLOGIC; DNA, VIRAL; HERPESVIRUS 8, HUMAN; HUMANS; KILLER CELLS, NATURAL; SARCOMA, KAPOSI;

EID: 0036772377     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(2002010)32:10<2711::AID-IMMU2711>3.0.CO;2-3     Document Type: Article

References (38)

1. Ensoli, B., Stürzl, M. and Monini, P., Reactivation and role of HHV-8 in Kaposi's sarcoma initiation. Adv. Cancer Res. 2001. 81: 161-200.
2. Stürzl, M., Zietz, C., Monini, P. and Ensoli, B., Human herpesvirus-8 and Kaposi's sarcoma: relationship with the multi-step concept of tumorigenesis. Adv. Cancer Res. 2001. 81: 125-159.
3. Chang, Y., Cesarman, E., Pessin, M. S., Lee, F., Culpepper, J., Knowles, D. M. and Moore, P. S., Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994. 266: 1865-1869.
4. Monini, P., Colombini, S., Stürzl, M., Goletti, D., Cafaro, A., Sgadari, C., Buttò, S., Franco, M., Leone, P., Fais, S., Leone, P., Melucci-Vigo, G., Chiozzini, C., Carlini, F., Ascherl, G., Cornali, E., Zietz, C., Ramazzotti, E., Ensoli, F., Andreoni, M., Pezzotti, P., Rezza, G., Yarchoan, R., Gallo, R. C. and Ensoli, B., Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma. Blood 1999. 93: 4044-4058.
5. Browning, P. J., Sechler, J. M., Kaplan, M., Washington, R. H., Gendelman, R., Yarchoan, R., Ensoli, B. and Gallo, R. C., Identification and culture of Kaposi's sarcoma-like spindle cells from the peripheral blood of human immunodeficiency virus-1-infected individuals and normal controls. Blood 1994. 84: 2711-2720.
6. Davis, M. A., Stürzl, M., Blasig, C., Schreier, A., Guo, H.G., Reitz, M., Opalenik, S. R. and Browning, P. J., Expression of human herpesvirus 8-encoded cyclin D in Kaposi's sarcoma spindle cells. J. Natl. Cancer Inst. 1997. 89: 1868-1874.
7. Sirianni, M. C., Uccini, S., Angeloni, A., Faggioni, A., Cottoni, F. and Ensoli, B., Circulating spindle cells: correlation with human herpesvirus-8 (HHV-8) infection and Kaposi's sarcoma. Lancet 1997. 349: 255.
8. Blasig, C., Zietz, C., Haar, B., Neipel, F., Esser, S., Brockmeyer, N. H., Tschachler, E., Colombini, S., Ensoli, B. and Stürzl, M., Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8. J. Virol. 1997. 71: 7963-7968.
9. Stürzl, M., Hohenadl, C., Zietz, C., Castanos-Velez, E., Wunderlich, A., Ascherl, G., Biberfeld, P., Monini, P., Browning, P. J. and Ensoli, B., Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi's sarcoma spindle cells. J. Natl. Cancer Inst. 1999. 91: 1725-1733.
10. Dupin, N., Fisher, C., Kellam, P., Ariad, S., Tulliez, M., Franck, N., van Marck, E., Salmon, D., Gorin, I., Escande, J. P., Weiss, R. A., Alitalo, K. and Boshoff, C., Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc. Natl. Acad. Sci. USA 1999. 96: 4546-4551.
11. Sirianni, M. C., Vincenzi, L., Fiorelli, V., Topino S., Scala, E., Uccini, S., Angeloni, A., Faggioni, A., Cerimele, D., Cottoni, F., Aiuti, F. and Ensoli, B., Gamma-interferon production in peripheral blood mononuclear cells and tumor infiltrating lymphocytes from Kaposi's sarcoma patients: correlation with the presence of human herpesvirus-8 in peripheral blood mononuclear cells and lesional macrophages. Blood 1998. 91: 968-976.
12. Osman, M., Kubo, T., Gill, J., Neipel, F., Becker, M., Smith, G., Weiss, R., Gazzard, B., Boshoff, C. and Gotch, F., Identification of human herpesvirus 8-specific cytotoxic T cell responses. J. Virol. 1999. 73: 6136-6140.
13. Strickler, H. D., Goedert, J. J., Bethke, F. R., Trubey, C. M., O'Brien, T. R., Palefsky, J., Whitman, J. E., Ablashi, D., Zeichner, S. and Shearer, G. M., Human herpesvirus 8 cellular immune responses in homosexual men. J. Infect. Dis. 1999. 180: 1682-1685.
14. Wang, Q. J., Jenkins, F. J., Jacobson, L. P., Kingsley, L. A., Day, R. D., Zhang, Z. W., Meng, Y. X., Pellet, P. E., Kousoulas, K. G., Baghian, A. and Rinaldo, C. R. Jr., Primary human herpesvirus 8 infection generates a broadly specific CD8(+) T cell response to viral lytic cycle proteins. Blood 2001. 97: 2366-2373.
15. + cytotoxic T lymphocyte responses to lytic proteins of human herpesvirus 8 in human immunodeficiency virus type 1-infected and -uninfected individuals. J. Infect. Dis. 2000. 182: 928-932.
16. Wilkinson, J., Cope, A., Gill, J., Bourboulia, D., Hayes, P., Imami, N., Kubo, T., Marcelin, A., Calvez, V., Weiss, R., Gazzard, B., Boshoff, C. and Gotch, F., Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type-1 infected patients receiving highly active antiretroviral therapy. J. Virol. 2002. 76: 2634-2640.
17. Coscoy, L. and Ganem, D., Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc. Natl. Acad. Sci. USA 2000. 97: 8051-8056.
18. Haque, M., Chen, J., Ueda, K., Mori, Y., Nakano, K., Hirata, Y., Kanamori, S., Uchiyama, Y., Inagi, R., Okuno, T. and Yamanishi, K., Identification and analysis of the K5 gene of Kaposi's sarcoma- associated herpesvirus. J. Virol. 2000. 74: 2867-2875.
19. Ishido, S., Wang, C., Lee, B. S., Cohen, G. B. and Jung, J. U., Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J. Virol. 2000. 74: 5300-5309.
20. Ishido, S., Choi, J. K., Lee, B. S., Wang, C., DeMaria, M., Johnson, R. P., Cohen, G. B. and Jung, J. U., Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein. Immunity. 2000. 13: 365-374.
21. Rimessi, P., Bonaccorsi, A., Stürzl, M., Fabris, M., Brocca-Cofano, E., Caputo, A., Melucci-Vigo, G., Falchi, M., Cafaro, A., Cassai, E., Ensoli, B. and Monini, P., Transcription pattern of human herpesvirus 8 open reading frame K3 in primary effusion lymphoma and Kaposi's sarcoma. J. Virol. 2001. 75: 7161-7174.
22. Brander, C., Suscovich, T., Lee, Y., Nguyen, P. T., O'Connor, P., Seebach, J., Jones, N. G., van Gorder, M., Walker, B. D. and Scadden, D. T., Impaired CTL recognition of cells latently infected with Kaposi's sarcoma-associated herpesvirus. J. Immunol. 2000. 165: 2077-2083.
23. Djerbi, M., Screpanti, V., Catrina, A. I., Bogen, B., Biberfeld, P. and Grandien, A., The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors. J. Exp. Med. 1999. 190: 1025-1032.
24. Trinchieri, G., Biology of natural killer cells. Adv. Immunol. 1989. 47: 187-376.
25. Lebbè, C., Blum, L., Pellet, C., Blanchard, G., Verola, O., Morel, P., Danne, O. and Calvo, F., Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma, AIDS 1998. 12: F45-F49.
26. International Collaboration on HIV and Cancer, Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J. Natl. Cancer Inst. 2000. 92: 1823-1830.
27. Sgadari, C., Barillari, G., Toschi, E., Carlei, D., Bacigalupo, I., Baccarini, S., Palladino, C., Leone, P., Bugarini, R., Malavasi, L., Cafaro, A., Falchi, M., Valdembri, D., Rezza, G., Bussolino, F., Monini, P. and Ensoli, B., HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi's sarcoma. Nat. Med. 2002. 8: 225-232.
28. Ensoli, B., Stürzl, M. and Monini, P., Cytokine-mediated growth promotion of Kaposi's sarcoma and primary effusion lymphoma. Semin. Cancer Biol. 2000. 10: 367-381
29. Krown, S. E., Metroka, C. and Wernz, J. C., Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee. J. Clin. Oncol. 1989. 7: 1201-1207.
30. Schatz, O., Monini, P., Bugarini, R., Neipel, F., Schulz, T. F., Andreoni, M., Erb, P., Eggers, M., Haas, J., Buttò, S., Lukwiya, M., Bogner, J. R., Yaguboglu, S., Sheldon, J., Sarmati, L., Goebel, F. D., Hintermaier, R., Enders, G., Regamey, N., Wernli, M., Stürzl, M., Rezza, G. and Ensoli, B., Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assays. J. Med. Virol. 2001. 65: 123-132.
31. Monini, P., Sirianni, M. C., Franco, M., Vincenzi, L., Topino, S., Goletti, D., Leone, P., Leone, P., Nicastri, E., Andreoni, M., Barduagni, O., Sgadari, C., Rezza, G., Stürzl, M. and Ensoli, B., Clearance of human herpesvirus 8 from blood and regression of leukopenia-associated aggressive classic Kaposi's sarcoma (KS) upon α-interferon therapy: a case report. Clin. Infect. Dis. 2001. 33: 1782-1785.
32. Ullum, H., Gotzsche, P. C., Victor, J., Dickmeiss, E., Skinhoj, P. and Pedersen, B. K., Defective natural immunity: an early manifestation of human immunodeficiency virus infection. J. Exp. Med. 1995. 182: 789-799.
33. Sirianni, M. C., Soddu, S., Malorni, W., Arancia, G. and Aiuti, F., Mechanism of defective natural killer cell activity in patients with AIDS is associated with defective distribution of tubulin. J. Immunol. 1988. 140: 2565-2568.
34. Sirianni, M. C., Ensoli, F., Alario, C., Fiorelli, V., Sacco, G., Topino, S., Iebba, F., Mezzaroma, I. and Aiuti, F., Distribution of the natural killer-related receptor for HLA-C during highly active antiretroviral therapy for human immunodeficiency virus infection [erratum published Hum. Immunol. 2002. 63: 336-336]. Hum. Immunol. 2001. 62: 1328-1334.
35. Gerosa, F., Baldani-Guerra, B., Nisii, C., Marchesini, V., Carra, G. and Trinchieri, G., Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 2002. 195: 327-333.
36. Soumelis, V., Scott, I., Gheyas, F., Bouhour, D., Cozon, G., Cotte, L., Huang, L., Levy, J. A. and Liu, Y. J., Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients. Blood 2001. 98: 906-912.
37. Quinnan, G. V., Jr., Kirmani, N., Rook, A. H., Manischewitz, J. F., Jackson, L., Moreschi, G., Santos, G. W., Saral, R. and Burns, W. H., Cytotoxic T cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone marrow-transplant recipients. N. Engl. J. Med. 1982. 307: 7-13.
38. Sullivan, J. L., Byron, K. S., Brewster, F. E. and Purtilo, D. T., Deficient natural killer cell activity in X-linked lymphoproliferative syndrome. Science 1980. 210: 543-545.